Cardiovascular and respiratory diseases account for a significant proportion of global morbidity and mortality, placing an immense burden on healthcare systems and economies in Quebec, across Canada, and worldwide. At McGill University, pioneering research in this field enables the development of innovative treatments and preventive strategies, significantly improving patient outcomes and quality of life. By exploring the molecular, genetic, and clinical aspects of cardiovascular and respiratory health, our research contributes to shaping precision medicine approaches, facilitating early detection, and driving advancements in personalized therapies.
Med student Madeline Yaaka on track to become first Inuk physician from Nunavik Madeline Yaaka made history when she entered McGill’s MDCM program last month…